PHARMACY

SEC declares S-4 of Pfizer effective for Wyeth acquisition

BY Alaric DeArment

NEW YORK The Securities and Exchange Commission declared effective a registration statement on a form that Pfizer submitted as part of its acquisition of Wyeth, Pfizer announced Thursday.

The Form S-4 registers with the SEC the common stock Pfizer will issue in connection with the acquisition, and includes Wyeth’s proxy statement for its annual meeting of stockholders, which it will convene Saturday, June 20, in Morristown, N.J., and which will include a vote on the merger.

Wyeth’s board of directors has agreed to the acquisition and will recommend that stockholders vote in favor of it, Wyeth announced Thursday. If the stockholders approve, and if other customary closing conditions are met, the company expects the acquisition to be completed in third or fourth quarter 2009.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Covidien enters a license, development collaboration with Nuvo Research

BY Alaric DeArment

ST. LOUIS A healthcare products company hopes to expand its entry into the branded painkiller market through a new deal with a Canadian drug development company.

Covidien announced that it had entered a license and development collaboration with Mississauga, Ontario-based Nuvo Research, which develops transdermal and topical drugs. The collaboration includes a topical painkiller that combines the nonsteroidal, anti-inflammatory drug diclofenac sodium with the transdermal carrier dimethyl sulfoxide.

Covidien said that Nuvo would receive an upfront payment – which Covidien would expense in its fiscal third quarter – development and sales milestone payments and royalties.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

APhA ‘stands ready’ for reformed healthcare system

BY Alaric DeArment

WASHINGTON An organization representing the country’s pharmacists heralded comments by President Barack Obama before the American Medical Association Monday that mentioned members of the profession as playing a role in healthcare reform.

Pharmacists “stand ready” to be part of a reformed healthcare system, the American Pharmacists Association said in response.

The APhA said that evidence increasingly indicates pharmacists help keep healthcare costs in check through such services as medication therapy management, which includes educating patients on how to take prescription drugs properly and safely, and health screenings and immunizations.

“We need to build on the examples of outstanding medicine at places like the Cincinnati Children’s Hospital, where the quality of care for cystic fibrosis patients shot up after the hospital began incorporating suggestions from parents,” Obama said in his remarks before the AMA’s annual conference in Chicago. “And places like Tallahassee Memorial Health Care, where deaths were dramatically reduced with rapid response teams that monitored patients’ conditions and ‘multidisciplinary rounds’ with everyone from physicians to pharmacists.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?